Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycolysis is a central metabolic pathway that breaks down glucose into pyruvate, generating ATP and NADH. It is an anaerobic process occurring in the cytoplasm of cells. The pathway consists of ten enzyme-catalyzed reactions divided into an investment phase and a payoff phase. Regulation occurs at key enzymatic steps, including hexokinase, phosphofructokinase, and pyruvate kinase. The fate of pyruvate depends on oxygen availability, leading to either the citric acid cycle or lactate production.
Inhibition or activation of key glycolytic enzymes (e.g., hexokinase, PFK1, pyruvate kinase)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycolysis.